Developer docs
API playgroundTry for free, no card

Search company profiles

Sydney Neuroimaging Analysis Centre

Full company profile

uuid000lmim

Namestring
Sydney Neuroimaging Analysis Centre
Legal namestring
Sydney Neuroimaging Analysis Centre Pty Ltd
Websiteurl
snac.com.au
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Sydney Neuroimaging Analysis Centre (SNAC) is a private Australian medical-imaging AI company founded in 2012 and co-located within the University of Sydney's Brain and Mind Centre. The company builds and commercializes regulatory-cleared deep-learning software for quantitative analysis of brain MRI and CT scans, with its flagship iQ-solutions™ platform (FDA 510(k)-cleared, TGA Class II) offering sub-millimetre-precision segmentation and longitudinal tracking of brain structures, lesions, and atrophy via modules iQ-MS™ (multiple sclerosis monitoring) and iQ-COG™ (cognitive dysfunction and dementia assessment). Its second core product, VeriScout™, is a TGA Class IIb-approved AI solution that automatically detects and triages cerebral haemorrhage on non-contrast head CT. Both run over Torana™, a vendor-neutral DICOM/HL7 medical-imaging gateway that integrates the outputs directly into customer PACS/RIS workflows with no additional radiologist clicks.

SNAC operates two distinct but complementary revenue streams. The first is a subscription SaaS/SaMD model in which iQ-Solutions and VeriScout are deployed enterprise-wide across radiology networks and hospitals (I-MED Radiology Network across 100+ clinics, Qscan Group, St Vincent's Hospital Sydney, North Shore Radiology, Synergy Radiology). The second is a central MRI reading and imaging-clinical-trial services business for pharmaceutical sponsors (Biogen, Roche, Novartis, Sanofi, Clene Nanomedicine) running Phase II-IV trials in MS, dementia, and neurodegenerative disease, delivered under ISO 9001, ISO 13485, and CFR 21 Part 11 compliance. The company is co-led by co-founder and COO Dr Chenyu (Tim) Wang and CRO Prof. Michael Barnett, with a CCO (John Moulden) added to drive commercial expansion.

Short descriptiontext

Sydney Neuroimaging Analysis Centre (SNAC) builds FDA- and TGA-cleared AI software (iQ-solutions, VeriScout, Torana) for quantitative brain MRI and CT analysis, serving Australian radiology networks, hospitals, and pharmaceutical clinical trial sponsors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCamperdown, Australia
HQ citystring
Camperdown
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI neuroimaging analysis, brain MRI quantification, medical imaging software, clinical trial imaging services, PACS imaging integration
Industry4 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACANAD
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAI
Imaging Informatics & Workflow (PACS/RIS/VNA)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services541690
  • Computer Systems Design and Related Services54151
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Health Services8000
  • Services-Computer Programming Services7371
Product category
Medical Imaging AI Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1iQ-Solutions SaaS/SaMD Subscriptions
TypeSubscription Recurring
Description

AI-powered neuroimaging analysis software delivered as a subscription-based SaaS model, deployed enterprise-wide across radiology networks and hospitals. Revenue generated through per-clinic or per-scan subscription fees.

snac.com.au
2Clinical Trial Imaging Services
TypeSubscription Recurring
Description

Full suite of regulatory-compliant central MRI reading services for Phase II-IV pharmaceutical clinical trials. Includes trial design consultation, site certification, scan management, and reporting. Revenue from study contracts with pharma sponsors.

snac.com.au
3Torana™ Medical Imaging Gateway
TypeSubscription Recurring
Description

Class I medical device software for medical image management, routing and databasing. Can be sold as a licensed product with ongoing support and maintenance fees.

snac.com.au
4Consulting and Professional Services
TypeProfessional Services
Description

Imaging informatics consulting, custom pipeline development, biomarker creation for investigator-driven studies, and education/training workshops for industry partners.

snac.com.au
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Technology or R&D, Infrastructure
Pricing details1 tier
1Enterprise subscription for radiology networks
ModelSubscriptionBilling cadenceAnnual
Notes

Enterprise deployment across large radiology networks (e.g., I-MED's 100+ clinics). Pricing likely scales with network size and scan volume. Subscription model confirmed; specific tiers not publicly disclosed.

snac.com.au
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1iQ-solutions
Description

AI-powered quantitative brain MRI analysis software platform (FDA 510(k) cleared, TGA Class II/IIb listed) with iQ-MS and iQ-COG modules for monitoring multiple sclerosis and cognitive dysfunction.

snac.com.au
+2 more records
Core offering1 text field

SNAC develops and sells AI-powered software as a medical device (SaMD) for quantitative neuroimaging analysis, including iQ-solutions for brain MRI quantification (iQ-MS for multiple sclerosis and iQ-COG for cognitive dysfunction/dementia), VeriScout for CT cerebral hemorrhage detection, and Torana as a medical imaging gateway for PACS/RIS integration. The company also provides central MRI reading services for Phase II-IV pharmaceutical clinical trials, plus imaging informatics consulting, research services, and education/training.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • iQ-Solutions achieves 93.3% sensitivity vs 58.3% for standard radiology reports in detecting active MS disease (new/enlarging lesions) in a multicentre real-world cohort of 397 MRI scan pairs
+3 more records
Product overview1 text field

SNAC offers a unified platform-plus-modules architecture centered on AI-powered medical imaging analysis. The core offering is iQ-solutions™ (comprising iQ-MS™ for MS monitoring and iQ-COG™ for cognitive assessment), which delivers quantitative MRI analysis through PACS-integrated workflows. This is complemented by VeriScout™ for CT hemorrhage detection and Torana™ as the underlying medical imaging gateway that enables all products to integrate with hospital PACS, RIS, and research systems. The portfolio covers the full spectrum from clinical trials central reading services to direct clinical deployment across radiology networks.

Product and service3 records
1iQ-solutions
CategoryNeuroimaging AI Software
Description

FDA 510(k)-cleared and TGA Class II AI-powered software platform providing submillimeter-precision quantitative analysis of brain MRI scans for monitoring chronic neurological diseases. Delivered as a 'zero-click' solution integrated with clinical PACS workflows.

2iQ-MS
CategoryNeuroimaging AI Software
Description

AI module for multiple sclerosis monitoring providing automated lesion segmentation, quantification of white matter hyperintensities, and longitudinal tracking of brain volume changes against normative data.

3iQ-COG
Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-13
Description

Enterprise deployment of SNAC's iQ-solutions™ platform (iQ-MS™ and iQ-COG™) across I-MED's network of 100+ MRI clinics in Australia. iQ-solutions provides quantitative brain MRI insights complementing I-MED's sub-specialist radiologist expertise for assessment and monitoring of MS and cognitive dysfunction.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-04
Description

Enterprise deployment of iQ-Solutions (iQ-MS and iQ-COG) across Qscan Group's radiology network, enabling consistent quantitative brain MRI insights for clinicians and referrers across Qscan's sites. Qscan Group is a premier Australian neuroimaging centre.

Strategic tierSecondaryTypeStrategic or Co-development PartnerAnnounced on2025-02-24
Description

Initial deployment of iQ-solutions at Qscan's premier neuroimaging centre on the Gold Coast, marking a step forward in advanced imaging technology for chronic neurological disease monitoring.

Strategic tierSecondaryTypeStrategic or Co-development PartnerAnnounced on2025-02-13
Description

Partnership to complement state-of-the-art MRI at North Shore Radiology with SNAC's AI-based precision brain analysis tool iQ-Solutions for enhanced monitoring and management of MS and cognitive conditions.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-06-10
Description

Multi-year strategic collaboration for development and deployment of AI-based solutions for rapid triage of critical imaging abnormalities in emergency departments and enhanced monitoring of chronic neurological disease patients. Leverages complementary resources including AI engineers, radiologists, imaging analysts, and clinical data.

Strategic tierSecondaryTypeStrategic or Co-development PartnerAnnounced on2022-02-16
Description

Multi-year collaboration agreement to integrate SNAC's AI technologies into Synergy Radiology's existing workflows, enhancing diagnostic productivity and precision imaging for neurological disease patients. Synergy Radiology is part of Qualitas Healthcare Group.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-11-11
Description

Co-development of TRANSCEND federated learning platform using NVIDIA Clara Train SDK and CLARA Federated Learning frameworks. Partnership dates to 2017 for quantifiable neuroimaging analysis and expanded in 2020 for multi-centre AI medical imaging platform under MRFF initiative. NVIDIA provides GPU technology and NVFlare federated learning runtime.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Key partner in MSBase Imaging Repository (MSBIR) initiative. SNAC provides iQ-MS analytics, Torana for data retrieval and de-identification, and COEUS for metadata search. MSBIR integrates imaging-clinical data across 10 global sites for MS research, supporting ~850 researchers and ~80,000 patients on MSBase platform.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

SNAC is co-located within and deeply collaborates with the University of Sydney's Brain and Mind Centre. The computational neuroscience team provides AI research capabilities. SNAC was co-founded by Professor Michael Barnett from the Brain and Mind Centre. The partnership secured A$2.36M MRFF grant in 2018.

Strategic tierMinorTypeOthers
Description

Pharmaceutical partner for clinical trials. Roche is listed among SNAC's trusted partners, indicating involvement in clinical trial imaging services.

11GE
Strategic tierMinorTypeOthers
Description

GE (General Electric) is listed among SNAC's trusted partners, indicating collaborative work with major imaging hardware providers.

Strategic tierMinorTypeOthers
Description

Pharmaceutical partner for clinical trials. Listed among SNAC's trusted partners.

Strategic tierMinorTypeOthers
Description

Pharmaceutical partner for clinical trials in MS and neurological diseases. Listed among trusted partners.

Strategic tierMinorTypeOthers
Description

Pharmaceutical partner for clinical trials. Listed among SNAC's trusted partners.

Strategic tierMinorTypeOthers
Description

Pharmaceutical sponsor for neurodegenerative disease clinical trials. SNAC provided central MRI reading for Clene's clinical development program.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

icometrix develops AI-based software (icobrain) for quantitative analysis of brain MRI/CT scans in MS, dementia, and traumatic brain injury. Closest direct peer to SNAC — same product category (neuroimaging AI SaMD), same therapeutic focus (MS, dementia), and same PACS-integrated deployment model to radiology networks and pharma sponsors.

TypeDirect peer
Description

RapidAI provides AI-powered neuroimaging software for stroke and other neurological conditions, with FDA-cleared products deployed in hospital systems globally. Competes with SNAC's VeriScout in CT-based emergency neuroimaging and serves overlapping radiology/hospital customers.

TypeDirect peer
Description

Viz.ai develops AI-powered care coordination and image analysis for stroke and other acute conditions. Competes with SNAC's VeriScout on AI triage of critical brain CT findings and shares the same enterprise SaaS go-to-market to hospital networks.

TypeDirect peer
Description

Aidoc offers AI-driven clinical decision support across multiple imaging modalities including brain CT for hemorrhage detection. Overlaps with SNAC's VeriScout and broader radiology AI workflow integration via PACS, though Aidoc's portfolio extends beyond neuro.

TypeDirect peer
Description

Brainomix develops AI-powered imaging biomarkers for stroke and cerebrovascular disease with FDA-cleared and CE-marked products. Direct competitor in the AI brain CT/Stroke imaging space with similar hospital SaaS deployment model.

TypeDirect peer
Description

Qure.ai develops AI algorithms for medical imaging, including head CT for hemorrhage detection (qER) and other radiology applications. Competes with SNAC's VeriScout in AI-enabled emergency brain CT interpretation, with global deployment.

TypeEmerging player
Description

Subtle Medical develops AI-powered image enhancement software for MRI and PET imaging, focused on faster acquisition and improved quality. Adjacent to SNAC's MRI workflow solutions, with partial overlap on neuroimaging AI use cases.

TypeBroad incumbent
Description

Arterys (now part of Tempus) developed a cloud-based AI platform for medical imaging including cardiac and lung applications. Comparable as an AI imaging SaaS platform with radiology network deployments, though broader than SNAC's neuro focus.

TypeEmerging player
Description

Blackford Analysis provides a centralized AI platform for radiology image analysis, integrating multiple third-party AI algorithms into radiology workflows. Comparable to SNAC's Torana gateway in enabling multi-AI deployment across PACS/RIS systems.

TypeRegional player
Description

Median Technologies provides imaging solutions and AI-based image analysis services for clinical trials and routine clinical practice, primarily serving European and US pharma sponsors. Comparable to SNAC's central reading and clinical trial imaging services business.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sydney Neuroimaging Analysis Centre

Medical Imaging AI Softwaresnac.com.au

Sydney Neuroimaging Analysis Centre (SNAC) builds FDA- and TGA-cleared AI software (iQ-solutions, VeriScout, Torana) for quantitative brain MRI and CT analysis, serving Australian radiology networks, hospitals, and pharmaceutical clinical trial sponsors.

What Sydney Neuroimaging Analysis Centre does

Sydney Neuroimaging Analysis Centre (SNAC) is a private Australian medical-imaging AI company founded in 2012 and co-located within the University of Sydney's Brain and Mind Centre. The company builds and commercializes regulatory-cleared deep-learning software for quantitative analysis of brain MRI and CT scans, with its flagship iQ-solutions™ platform (FDA 510(k)-cleared, TGA Class II) offering sub-millimetre-precision segmentation and longitudinal tracking of brain structures, lesions, and atrophy via modules iQ-MS™ (multiple sclerosis monitoring) and iQ-COG™ (cognitive dysfunction and dementia assessment). Its second core product, VeriScout™, is a TGA Class IIb-approved AI solution that automatically detects and triages cerebral haemorrhage on non-contrast head CT. Both run over Torana™, a vendor-neutral DICOM/HL7 medical-imaging gateway that integrates the outputs directly into customer PACS/RIS workflows with no additional radiologist clicks.

SNAC operates two distinct but complementary revenue streams. The first is a subscription SaaS/SaMD model in which iQ-Solutions and VeriScout are deployed enterprise-wide across radiology networks and hospitals (I-MED Radiology Network across 100+ clinics, Qscan Group, St Vincent's Hospital Sydney, North Shore Radiology, Synergy Radiology). The second is a central MRI reading and imaging-clinical-trial services business for pharmaceutical sponsors (Biogen, Roche, Novartis, Sanofi, Clene Nanomedicine) running Phase II-IV trials in MS, dementia, and neurodegenerative disease, delivered under ISO 9001, ISO 13485, and CFR 21 Part 11 compliance. The company is co-led by co-founder and COO Dr Chenyu (Tim) Wang and CRO Prof. Michael Barnett, with a CCO (John Moulden) added to drive commercial expansion.

Sydney Neuroimaging Analysis Centre firmographics

Firmographics
Name
Sydney Neuroimaging Analysis Centre
Legal name
Sydney Neuroimaging Analysis Centre Pty Ltd
Website
https://snac.com.au
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
Sydney Neuroimaging Analysis Centre (SNAC) builds FDA- and TGA-cleared AI software (iQ-solutions, VeriScout, Torana) for quantitative brain MRI and CT analysis, serving Australian radiology networks, hospitals, and pharmaceutical clinical trial sponsors.
Ownership category
akta.pro rank

Sydney Neuroimaging Analysis Centre industry classification

Industry
Product category
Medical Imaging AI Software
NAICS
Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690), Computer Systems Design and Related Services (54151)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Health Services (8000), Services-Computer Programming Services (7371)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACANAD
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAI
Imaging Informatics & Workflow (PACS/RIS/VNA)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • AI neuroimaging analysis
  • Brain MRI quantification
  • Medical imaging software
  • Clinical trial imaging services
  • PACS imaging integration

Where Sydney Neuroimaging Analysis Centre is headquartered

Location

Headquarters

HQ city
Camperdown
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Sydney Neuroimaging Analysis Centre business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure

Revenue model

  1. iQ-Solutions SaaS/SaMD Subscriptions: AI-powered neuroimaging analysis software delivered as a subscription-based SaaS model, deployed enterprise-wide across radiology networks and hospitals. Revenue generated through per-clinic or per-scan subscription fees.
  2. Clinical Trial Imaging Services: Full suite of regulatory-compliant central MRI reading services for Phase II-IV pharmaceutical clinical trials. Includes trial design consultation, site certification, scan management, and reporting. Revenue from study contracts with pharma sponsors.
  3. Torana™ Medical Imaging Gateway: Class I medical device software for medical image management, routing and databasing. Can be sold as a licensed product with ongoing support and maintenance fees.
  4. Consulting and Professional Services: Imaging informatics consulting, custom pipeline development, biomarker creation for investigator-driven studies, and education/training workshops for industry partners.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise subscription for radiology networks

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Sydney Neuroimaging Analysis Centre product offering

Product offering

Core offering

SNAC develops and sells AI-powered software as a medical device (SaMD) for quantitative neuroimaging analysis, including iQ-solutions for brain MRI quantification (iQ-MS for multiple sclerosis and iQ-COG for cognitive dysfunction/dementia), VeriScout for CT cerebral hemorrhage detection, and Torana as a medical imaging gateway for PACS/RIS integration. The company also provides central MRI reading services for Phase II-IV pharmaceutical clinical trials, plus imaging informatics consulting, research services, and education/training.

Product overview

SNAC offers a unified platform-plus-modules architecture centered on AI-powered medical imaging analysis. The core offering is iQ-solutions™ (comprising iQ-MS™ for MS monitoring and iQ-COG™ for cognitive assessment), which delivers quantitative MRI analysis through PACS-integrated workflows. This is complemented by VeriScout™ for CT hemorrhage detection and Torana™ as the underlying medical imaging gateway that enables all products to integrate with hospital PACS, RIS, and research systems. The portfolio covers the full spectrum from clinical trials central reading services to direct clinical deployment across radiology networks.

Differentiator

Problem solved

Functional benefit

Brands

  • iQ-solutions: AI-powered quantitative brain MRI analysis software platform (FDA 510(k) cleared, TGA Class II/IIb listed) with iQ-MS and iQ-COG modules for monitoring multiple sclerosis and cognitive dysfunction.
  • Torana
  • VeriScout

Products and services

  • iQ-solutions FDA 510(k)-cleared and TGA Class II AI-powered software platform providing submillimeter-precision quantitative analysis of brain MRI scans for monitoring chronic neurological diseases. Delivered as a 'zero-click' solution integrated with clinical PACS workflows.
  • iQ-MS AI module for multiple sclerosis monitoring providing automated lesion segmentation, quantification of white matter hyperintensities, and longitudinal tracking of brain volume changes against normative data.
  • iQ-COG

Quantifiable outcome

  • iQ-Solutions achieves 93.3% sensitivity vs 58.3% for standard radiology reports in detecting active MS disease (new/enlarging lesions) in a multicentre real-world cohort of 397 MRI scan pairs
  • +3 more outcomes

Companies that use Sydney Neuroimaging Analysis Centre

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Sydney Neuroimaging Analysis Centre technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability10 records

Feature8 records

Sydney Neuroimaging Analysis Centre partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered core, secondary and minor.

  • I-MED Radiology NetworkcoreStrategic or Co-development Partner · 13 May 2026Enterprise deployment of SNAC's iQ-solutions™ platform (iQ-MS™ and iQ-COG™) across I-MED's network of 100+ MRI clinics in Australia. iQ-solutions provides quantitative brain MRI insights complementing I-MED's sub-specialist radiologist expertise for assessment and monitoring of MS and cognitive dysfunction.
  • Qscan GroupcoreStrategic or Co-development Partner · 4 December 2025Enterprise deployment of iQ-Solutions (iQ-MS and iQ-COG) across Qscan Group's radiology network, enabling consistent quantitative brain MRI insights for clinicians and referrers across Qscan's sites. Qscan Group is a premier Australian neuroimaging centre.
  • Qscan Group (Gold Coast)secondaryStrategic or Co-development Partner · 24 February 2025Initial deployment of iQ-solutions at Qscan's premier neuroimaging centre on the Gold Coast, marking a step forward in advanced imaging technology for chronic neurological disease monitoring.
  • North Shore Radiology and Nuclear MedicinesecondaryStrategic or Co-development Partner · 13 February 2025Partnership to complement state-of-the-art MRI at North Shore Radiology with SNAC's AI-based precision brain analysis tool iQ-Solutions for enhanced monitoring and management of MS and cognitive conditions.
  • St Vincent's Hospital SydneycoreStrategic or Co-development Partner · 10 June 2022Multi-year strategic collaboration for development and deployment of AI-based solutions for rapid triage of critical imaging abnormalities in emergency departments and enhanced monitoring of chronic neurological disease patients. Leverages complementary resources including AI engineers, radiologists, imaging analysts, and clinical data.
  • Synergy RadiologysecondaryStrategic or Co-development Partner · 16 February 2022Multi-year collaboration agreement to integrate SNAC's AI technologies into Synergy Radiology's existing workflows, enhancing diagnostic productivity and precision imaging for neurological disease patients. Synergy Radiology is part of Qualitas Healthcare Group.
  • NVIDIAcoreTechnology or Integration · 11 November 2021Co-development of TRANSCEND federated learning platform using NVIDIA Clara Train SDK and CLARA Federated Learning frameworks. Partnership dates to 2017 for quantifiable neuroimaging analysis and expanded in 2020 for multi-centre AI medical imaging platform under MRFF initiative. NVIDIA provides GPU technology and NVFlare federated learning runtime.
  • MSBase / University of Sydney Brain and Mind CentrecoreStrategic or Co-development Partner · 1 January 2021Key partner in MSBase Imaging Repository (MSBIR) initiative. SNAC provides iQ-MS analytics, Torana for data retrieval and de-identification, and COEUS for metadata search. MSBIR integrates imaging-clinical data across 10 global sites for MS research, supporting ~850 researchers and ~80,000 patients on MSBase platform.
  • University of Sydney Brain and Mind CentrecoreStrategic or Co-development PartnerSNAC is co-located within and deeply collaborates with the University of Sydney's Brain and Mind Centre. The computational neuroscience team provides AI research capabilities. SNAC was co-founded by Professor Michael Barnett from the Brain and Mind Centre. The partnership secured A$2.36M MRFF grant in 2018.
  • RocheminorOthersPharmaceutical partner for clinical trials. Roche is listed among SNAC's trusted partners, indicating involvement in clinical trial imaging services.
  • GEminorOthersGE (General Electric) is listed among SNAC's trusted partners, indicating collaborative work with major imaging hardware providers.
  • NovartisminorOthersPharmaceutical partner for clinical trials. Listed among SNAC's trusted partners.
  • BiogenminorOthersPharmaceutical partner for clinical trials in MS and neurological diseases. Listed among trusted partners.
  • SanofiminorOthersPharmaceutical partner for clinical trials. Listed among SNAC's trusted partners.
  • Clene NanomedicineminorOthersPharmaceutical sponsor for neurodegenerative disease clinical trials. SNAC provided central MRI reading for Clene's clinical development program.

Scale indicators14 records

Recent moves8 records

Expansion highlights6 records

Sydney Neuroimaging Analysis Centre competitors and assessment

Company assessment

Direct peers

  • icometrix: icometrix develops AI-based software (icobrain) for quantitative analysis of brain MRI/CT scans in MS, dementia, and traumatic brain injury. Closest direct peer to SNAC — same product category (neuroimaging AI SaMD), same therapeutic focus (MS, dementia), and same PACS-integrated deployment model to radiology networks and pharma sponsors.
  • RapidAI: RapidAI provides AI-powered neuroimaging software for stroke and other neurological conditions, with FDA-cleared products deployed in hospital systems globally. Competes with SNAC's VeriScout in CT-based emergency neuroimaging and serves overlapping radiology/hospital customers.
  • Viz.ai: Viz.ai develops AI-powered care coordination and image analysis for stroke and other acute conditions. Competes with SNAC's VeriScout on AI triage of critical brain CT findings and shares the same enterprise SaaS go-to-market to hospital networks.
  • Aidoc: Aidoc offers AI-driven clinical decision support across multiple imaging modalities including brain CT for hemorrhage detection. Overlaps with SNAC's VeriScout and broader radiology AI workflow integration via PACS, though Aidoc's portfolio extends beyond neuro.
  • Brainomix: Brainomix develops AI-powered imaging biomarkers for stroke and cerebrovascular disease with FDA-cleared and CE-marked products. Direct competitor in the AI brain CT/Stroke imaging space with similar hospital SaaS deployment model.
  • Qure.ai: Qure.ai develops AI algorithms for medical imaging, including head CT for hemorrhage detection (qER) and other radiology applications. Competes with SNAC's VeriScout in AI-enabled emergency brain CT interpretation, with global deployment.

Emerging players

  • Subtle Medical: Subtle Medical develops AI-powered image enhancement software for MRI and PET imaging, focused on faster acquisition and improved quality. Adjacent to SNAC's MRI workflow solutions, with partial overlap on neuroimaging AI use cases.
  • Blackford Analysis: Blackford Analysis provides a centralized AI platform for radiology image analysis, integrating multiple third-party AI algorithms into radiology workflows. Comparable to SNAC's Torana gateway in enabling multi-AI deployment across PACS/RIS systems.

Broad incumbents

  • Arterys (Tempus): Arterys (now part of Tempus) developed a cloud-based AI platform for medical imaging including cardiac and lung applications. Comparable as an AI imaging SaaS platform with radiology network deployments, though broader than SNAC's neuro focus.

Regional players

  • Median Technologies: Median Technologies provides imaging solutions and AI-based image analysis services for clinical trials and routine clinical practice, primarily serving European and US pharma sponsors. Comparable to SNAC's central reading and clinical trial imaging services business.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Sydney Neuroimaging Analysis Centre social profiles

Digital presence

Sydney Neuroimaging Analysis Centre compliance and trust

Trust signal

Compliance7 records

Sydney Neuroimaging Analysis Centre financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sydney Neuroimaging Analysis Centre leadership team

Management profile

Number of profiles

Profiles10 records

Sydney Neuroimaging Analysis Centre funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sydney Neuroimaging Analysis Centre M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sydney Neuroimaging Analysis Centre

What does Sydney Neuroimaging Analysis Centre do?

SNAC develops and sells AI-powered software as a medical device (SaMD) for quantitative neuroimaging analysis, including iQ-solutions for brain MRI quantification (iQ-MS for multiple sclerosis and iQ-COG for cognitive dysfunction/dementia), VeriScout for CT cerebral hemorrhage detection, and Torana as a medical imaging gateway for PACS/RIS integration. The company also provides central MRI reading services for Phase II-IV pharmaceutical clinical trials, plus imaging informatics consulting, research services, and education/training.

Is Sydney Neuroimaging Analysis Centre a public or private company?

Sydney Neuroimaging Analysis Centre is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Sydney Neuroimaging Analysis Centre founded?

Sydney Neuroimaging Analysis Centre was founded in 2012. It employs 11 to 50 people.

Where is Sydney Neuroimaging Analysis Centre based?

Sydney Neuroimaging Analysis Centre is headquartered in Camperdown, Australia, in the Oceania region.

How does Sydney Neuroimaging Analysis Centre make money?

Four revenue lines are on record. iQ-Solutions SaaS/SaMD Subscriptions are the primary driver. The others are clinical Trial Imaging Services, torana™ Medical Imaging Gateway and consulting and Professional Services.

Who are Sydney Neuroimaging Analysis Centre's main competitors?

Direct peers on record are icometrix, RapidAI, Viz.ai, Aidoc, Brainomix and Qure.ai. Emerging players are Subtle Medical and Blackford Analysis. Arterys (Tempus) is listed as a broad incumbent. Median Technologies is listed as a regional player.

Does Sydney Neuroimaging Analysis Centre have an API?

No public API is recorded for Sydney Neuroimaging Analysis Centre.

What industry is Sydney Neuroimaging Analysis Centre in?

Sydney Neuroimaging Analysis Centre's product category is Medical Imaging AI Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 5417 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals